John Oidtman

John Oidtman is a skilled biopharmaceutical enterprise leader with extensive executive management experience, particularly in clinical and regulatory operations. They have held significant roles, including Chief Operating Officer at EMD Serono and Vice President at Pfizer, leading various clinical programs and operational improvements. Starting their career as a toxicologist, John transitioned to regulatory affairs and drove advancements in pharmaceutical R&D portfolios, successfully overseeing the commercialization of 21 products in healthcare. Currently, John serves as an advisor for OnKai Inc. and JOTerp Advisory LLC, and continues to provide strategic insights in the biopharmaceutical field. They have also earned degrees from the University of Maryland and completed business coursework at Stanford University and INSEAD.